Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer

PI3K/AKT/mTOR通路 蛋白激酶B 癌症研究 生物 转录组 下调和上调 癌症 信号转导 基因 遗传学 基因表达
作者
Ying Jin,Yamei Chen,Huarong Tang,Xiao Hu,Shawna Marie Hubert,Qian Li,Dan Su,Haimiao Xu,Yun Fan,Xinmin Yu,Qixun Chen,Jinshi Liu,Wei Hong,Yujin Xu,Huan Deng,Dapeng Zhu,Pansong Li,Yuhua Gong,Xuefeng Xia,Carl Michael Gay
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:28 (3): 526-539 被引量:119
标识
DOI:10.1158/1078-0432.ccr-21-1943
摘要

Purpose: Here, we have investigated treatment resistance mechanisms in small cell lung cancer (SCLC) by focusing on comparing the genotype and phenotype in tumor samples of treatment-resistant and treatment-sensitive SCLC. Experimental Design: We conducted whole-exome sequencing on paired tumor samples at diagnosis and relapse from 11 patients with limited-stage (LS)-SCLC and targeted sequencing of 1,021 cancer-related genes on cell-free DNA at baseline and paired relapsed samples from 9 additional patients with LS-SCLC. Furthermore, we performed label-free mass spectrometry–based proteomics on tumor samples from 28 chemo-resistant and 23 chemo-sensitive patients with extensive-stage (ES)-SCLC. The main findings were validated in vitro in chemo-sensitive versus chemo-resistant SCLC cell lines and analyses of transcriptomic data of SCLC cell lines from a public database. Results: Genomic analyses demonstrated that at relapse of LS-SCLC, genes in the PI3K/AKT signaling pathway were enriched for acquired somatic mutations or high-frequency acquired copy-number variants. Pathway analysis on differentially upregulated proteins from ES-SCLC cohort revealed enrichment in the HIF-1 signaling pathway. Importantly, 7 of 62 PI3K/AKT pathway genes containing acquired somatic copy-number amplifications were enriched in HIF-1 pathway. Analyses of transcriptomic data of SCLC cell lines from public databases confirmed upregulation of PI3K/AKT and HIF-1 pathways in chemo-resistant SCLC cell lines. Furthermore, chemotherapy-resistant cell lines could be sensitive to PI3K inhibitors in vitro. Conclusions: PI3K/AKT pathway activation may be one potential mechanism underlying therapeutic resistance of SCLC. This finding warrants further investigation and provides a possible approach to reverse resistance to chemo/radiotherapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小马甲的应助被Hongjun采纳,获得10
刚刚
刚刚
yuanyu发布了新的文献求助10
刚刚
susu完成签到 ,获得积分10
1秒前
小李完成签到 ,获得积分10
1秒前
霖宸羽完成签到,获得积分10
2秒前
dqhlm发布了新的文献求助10
2秒前
chemwd完成签到,获得积分10
2秒前
2秒前
爱睡觉的噜噜完成签到,获得积分10
3秒前
3秒前
qizhang完成签到,获得积分10
3秒前
斯文败类的应助被普洛望斯采纳,获得10
4秒前
zfy157619完成签到,获得积分10
4秒前
5秒前
6秒前
秋风的应助被柏笙笑采纳,获得20
6秒前
歪歪发布了新的文献求助10
7秒前
QingCress77完成签到 ,获得积分10
8秒前
8秒前
呓语完成签到 ,获得积分10
8秒前
8秒前
打打的应助被天青妖采纳,获得10
8秒前
领导范儿的应助被陌路采纳,获得10
9秒前
CipherSage的应助被感性的忆灵采纳,获得10
9秒前
饺子发布了新的文献求助10
9秒前
Jasper的应助被可靠松鼠采纳,获得10
9秒前
年轻怀绿完成签到,获得积分10
10秒前
10秒前
10秒前
10秒前
Hao完成签到 ,获得积分10
10秒前
科研小冯完成签到,获得积分10
11秒前
mabing完成签到 ,获得积分10
12秒前
乃带娃儿完成签到,获得积分10
12秒前
huanj完成签到,获得积分20
13秒前
ccshu发布了新的文献求助10
13秒前
热情的猪羔子完成签到,获得积分10
14秒前
14秒前
美丽发布了新的文献求助10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187652
求助须知:如何正确求助?哪些是违规求助? 9575758
关于积分的说明 21842805
捐赠科研通 7785538
什么是DOI,文献DOI怎么找? 3435073
关于科研通互助平台的介绍 2559480
邀请新用户注册赠送积分活动 2481963